Hepatitis is considered as the seventh leading cause of death throughout the world, where half of the deaths occur due to hepatitis B viral infection. Early cost-effective diagnosis could help in treating the affected patients without any delay.
A research team from the Rensselaer Polytechnic Institute has developed a blood test to detect autism by measuring metabolites from blood samples well in advance. The research work was recently published in Bioengineering & Translational Medicine.
At present, breast cancer patients need to wait for nearly two to three months to find out via a scan whether palbociclib is working. This new test could detect the circulating tumor DNA which enters the bloodstream. By measuring and comparing PIK3CA levels in a blood test before and 15 post palbociclib therapy, one could predict the effectiveness of the drug.
There was a major breakthrough for scientists from Australia who designed a new blood test named “painHS” to detect chronic pain through color biomarkers.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.